Cesano Alessandra 4
4 · Summit Therapeutics Inc. · Filed Nov 17, 2022
Insider Transaction Report
Form 4
Cesano Alessandra
Director
Transactions
- Award
Stock Option (right to buy)
2022-11-15+200,000→ 200,000 totalExercise: $1.09Exp: 2032-11-15→ Common Stock (200,000 underlying) - Award
Stock Option (right to buy)
2022-11-15+4,166→ 204,166 totalExercise: $1.09Exp: 2032-11-15→ Common Stock (4,166 underlying)
Footnotes (3)
- [F1]The option was granted on November 15, 2022. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 15, 2023.
- [F2]Not applicable.
- [F3]The option was granted on November 15, 2022 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days the Reporting Person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2022.